Stories

  • Dr. Kristen Hege – Pioneering Car-T Cell Therapy in Oncology

    Dr. Kristen Hege delivered a memorable keynote to our community, sharing wisdom gained from her transformative journey through academic medicine and biotech leadership.

  • Brazilian Delegation Visits MBC BioLabs to Explore the Future of Biotech

    The delegation was given an immersive tour of the facilities, showcasing cutting-edge laboratories, co-working spaces, and support services that MBC BioLabs offers to its resident companies.

  • Fika, A New MBC BioLabs Tradition! 

    According to Doug Crawford, there are a few key things that scientists need in order to succeed in the labs: one of them being coffee, and the other is snacks! Our newly adapted weekly tradition of Fika was inspired by the Swedish culture. Fika, which roughly translates from Swedish as drinking coffee, munching sweet treats and chatting — is as much a part of the working day in Sweden as emailing and fixing the printer. 

  • Ambagon Therapeutics

    By taming disordered proteins, Ambagon generates new possibilities across the proteome.

  • Celebrating “Small” Wins

    Traditionally, most of the events we celebrate in life are the big milestones we accomplish – birthdays, graduation, retirement, the first round of investments. Often, we are too focused on the “goal” or the “outcome” that we forget about the small steppingstones along the way; the “small wins” in our day-to-day lives that drive the initiative to accomplish even bigger milestones.

  • Cartography Biosciences

    Cartography emerged from stealth in July 2022 with $57 million in initial financing to create more precise immunotherapies.

  • Acelera Youth Group from Brazil

    MBC BioLabs welcomed 30 of Acelera Youth Group’s brightest minds from Brazil.

  • STEM Festival in Potrero Hill

    Our first STEM participation with Portrero Hill’s Stem Festival.

  • Mammoth Biosciences

    Mammoth Biosciences Raises $68M for its CRISPR Diagnostics

  • Alector

    Alector raised $185 million in IPO

  • Cell Design Labs

    Cell Design Labs wins big with Gilead acquisition.